97 related articles for article (PubMed ID: 11289752)
61. A case of metastatic medullary thyroid carcinoma: early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens.
Russo D; Arturi F; Chiefari E; Meringolo D; Bianchi D; Bellanova B; Filetti S
J Clin Endocrinol Metab; 1997 Oct; 82(10):3378-82. PubMed ID: 9329372
[TBL] [Abstract][Full Text] [Related]
62. A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy.
Dang GT; Cote GJ; Schultz PN; Khorana S; Decker RA; Gagel RF
Mol Cell Probes; 1999 Feb; 13(1):77-9. PubMed ID: 10024437
[TBL] [Abstract][Full Text] [Related]
63. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393
[TBL] [Abstract][Full Text] [Related]
64. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
[TBL] [Abstract][Full Text] [Related]
65. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
66. [Detection of RET-proto-oncogene mutations in the diagnosis of Type 2 endocrine neoplasia (MEN 2)].
Komminoth P; Muletta-Feurer S; Soltermann A; Gemsenjäger E; Bürgi H; Staub JJ; Schönle E; Fried M; Vetter W; Spinas GA; Heitz PU
Schweiz Med Wochenschr; 1996 Aug; 126(31-32):1329-38. PubMed ID: 8765374
[TBL] [Abstract][Full Text] [Related]
67. [Do you indicate surgery based only in genetic examination].
Tavares MR
Rev Assoc Med Bras (1992); 2002; 48(2):103. PubMed ID: 12205520
[No Abstract] [Full Text] [Related]
68. Thyroidectomy for genetically determined medullary carcinoma.
Williams ED
Lancet; 1977 Jun; 1(8025):1309-10. PubMed ID: 68405
[No Abstract] [Full Text] [Related]
69. History of a Case of Medullary Sarcoma, which affected several important Viscera, with a Description of the Morbid Appearances which were observed on Dissection.
Langstaff G
Med Chir Trans; 1833; 18(Pt 1):250-5. PubMed ID: 20895603
[No Abstract] [Full Text] [Related]
70. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Marsh DJ; Mulligan LM; Eng C
Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
[TBL] [Abstract][Full Text] [Related]
71. Preventive thyroidectomy in patients with hereditary medullary thyroid carcinoma found heterozygote for mutant RET proto-oncogene.
Konstantinou E; Sapsakos Mariolis T; Fotis T; Mitsos A; Restos S; Mamoura K; Soultati A; Elefsiniotis I; Kapellakis G
Pediatr Endocrinol Rev; 2010 Dec; 8(2):108-13. PubMed ID: 21150841
[TBL] [Abstract][Full Text] [Related]
72. Familial medullary thyroid carcinoma (FMTC). Study of one family (treatment criteria).
Carli AF; Mariani F; Di Cosmo L; Giuli R; Neri A
Eur J Surg Oncol; 2001 Mar; 27(2):162-4. PubMed ID: 11289752
[TBL] [Abstract][Full Text] [Related]
73. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation.
Feldman GL; Edmonds MW; Ainsworth PJ; Schuffenecker I; Lenoir GM; Saxe AW; Talpos GB; Roberson J; Petrucelli N; Jackson CE
Surgery; 2000 Jul; 128(1):93-8. PubMed ID: 10876191
[TBL] [Abstract][Full Text] [Related]
74. Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?
Hansen HS; Torring H; Godballe C; Jäger AC; Nielsen FC
Cancer; 2000 Aug; 89(4):863-7. PubMed ID: 10951350
[TBL] [Abstract][Full Text] [Related]
75. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.
Fitze G; Schierz M; Bredow J; Saeger HD; Roesner D; Schackert HK
Ann Surg; 2002 Nov; 236(5):570-5. PubMed ID: 12409662
[TBL] [Abstract][Full Text] [Related]
76. [Genetic testing for ret mutation for early diagnosis and treatment in familial medullary thyroid carcinoma: a case report].
Nagaoka H; Iino Y; Takei H; Maemura M; Horiguchi J; Horii Y; Matumoto H; Koibuchi Y; Ninomiya J; Yokoe T; Oyama T; Morishita Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():481-5. PubMed ID: 9589057
[TBL] [Abstract][Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
